NO20065144L - Krystallinsk clopidogrelnaftalensulfonat eller hydrat derav, fremgangsmate for fremstilling derav, og farmasoytisk preparat inneholdende dette - Google Patents

Krystallinsk clopidogrelnaftalensulfonat eller hydrat derav, fremgangsmate for fremstilling derav, og farmasoytisk preparat inneholdende dette

Info

Publication number
NO20065144L
NO20065144L NO20065144A NO20065144A NO20065144L NO 20065144 L NO20065144 L NO 20065144L NO 20065144 A NO20065144 A NO 20065144A NO 20065144 A NO20065144 A NO 20065144A NO 20065144 L NO20065144 L NO 20065144L
Authority
NO
Norway
Prior art keywords
hydrate
preparation
pharmaceutical composition
composition containing
crystalline clopidogrel
Prior art date
Application number
NO20065144A
Other languages
English (en)
Inventor
Gwan Sun Lee
Sangmin Yun
Eun Sook Kim
Hee Seock Kim
Bo Sung Kwon
Cheol Kyung Kim
Han Kyong Kim
Kwee-Hyun Suh
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020040041309A external-priority patent/KR100563455B1/ko
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of NO20065144L publication Critical patent/NO20065144L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Et krystallinsk clopidogrelnaftalensulfonat eller et hydrat derav, en fremgangsmåte for fremstilling derav, og et farmasøytisk preparat inneholdende dette, er tilveiebrakt.
NO20065144A 2004-04-09 2006-11-08 Krystallinsk clopidogrelnaftalensulfonat eller hydrat derav, fremgangsmate for fremstilling derav, og farmasoytisk preparat inneholdende dette NO20065144L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20040024361 2004-04-09
KR1020040041309A KR100563455B1 (ko) 2004-04-09 2004-06-07 결정성 클로피도그렐 나프탈렌술폰산염 또는 이의 수화물,이의 제조방법 및 이를 함유하는 약학적 조성물
PCT/KR2004/002665 WO2005097804A1 (en) 2004-04-09 2004-10-18 Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same

Publications (1)

Publication Number Publication Date
NO20065144L true NO20065144L (no) 2007-01-08

Family

ID=35061381

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065144A NO20065144L (no) 2004-04-09 2006-11-08 Krystallinsk clopidogrelnaftalensulfonat eller hydrat derav, fremgangsmate for fremstilling derav, og farmasoytisk preparat inneholdende dette

Country Status (13)

Country Link
US (1) US7470707B2 (no)
EP (2) EP2386560A1 (no)
JP (1) JP4550884B2 (no)
CN (1) CN1938319B (no)
AU (1) AU2004318214B2 (no)
BR (1) BRPI0418726A (no)
CA (1) CA2562532C (no)
HK (1) HK1098482A1 (no)
IL (1) IL177806A0 (no)
NO (1) NO20065144L (no)
NZ (1) NZ551153A (no)
RU (1) RU2328501C1 (no)
WO (1) WO2005097804A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2339944T3 (es) * 2003-11-03 2010-05-27 Cadila Healthcare Limited Procedimientos para preparar la forma i de bisulfato de (s)-(+)-clopidogrel.
GB0418580D0 (en) * 2004-08-21 2004-09-22 Ivax Pharmaceuticals Sro Clopidogrel salt
IS2385B (is) * 2006-02-10 2008-07-15 Actavis Group Hf. Klópidógrel bísúlfat lyfjasamsetningar
KR100945062B1 (ko) 2006-03-22 2010-03-05 한미약품 주식회사 클로피도그렐 1,5-나프탈렌디술폰산염 및 이의 수화물의제조방법
ES2306595B1 (es) * 2007-02-09 2009-09-11 Laboratorios Almirall S.A. Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
EP3766493B1 (en) 2007-04-27 2023-08-23 CyDex Pharmaceuticals, Inc. Method for improving the stability of clopidogrel using sulfoalkyl ether cyclodextrin
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US8236782B2 (en) 2009-05-13 2012-08-07 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
CN111620795B (zh) * 2020-04-27 2021-11-19 华东师范大学 芳基、烷基磺酸类化合物及采用无机硫盐的构建方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
JP2815691B2 (ja) * 1990-09-20 1998-10-27 麒麟麦酒株式会社 Ｋｒｎ２３９１酸付加塩およびその用途
US6133244A (en) * 1993-10-22 2000-10-17 Institut Pasteur Method for immunization against hepatitis B
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
WO2002059128A2 (en) 2001-01-24 2002-08-01 Cadila Healthcare Ltd. Process for preparing clopidogrel
ES2316650T3 (es) * 2001-12-18 2009-04-16 Teva Pharmaceutical Industries Ltd. Polimorfos de hidrogenosulfato de clopidogrel.
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
SE0201661D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab New salts
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
GB2393181A (en) * 2002-09-19 2004-03-24 Cipla Ltd Amorphous clopidogrel
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
AU2005214469A1 (en) * 2004-02-24 2005-09-01 Siegfried Generics International Ag Pharmacologically acceptable salts of clopidogrel
MXPA06012128A (es) * 2004-04-20 2007-01-31 Sanofi Aventis Sal de clopidogrel y formas polimorfas de la misma.

Also Published As

Publication number Publication date
HK1098482A1 (en) 2007-07-20
EP1732932A4 (en) 2010-04-21
EP1732932A1 (en) 2006-12-20
CN1938319A (zh) 2007-03-28
IL177806A0 (en) 2006-12-31
CN1938319B (zh) 2010-05-12
JP4550884B2 (ja) 2010-09-22
EP1732932B1 (en) 2012-03-21
US7470707B2 (en) 2008-12-30
WO2005097804A1 (en) 2005-10-20
EP2386560A1 (en) 2011-11-16
JP2007532530A (ja) 2007-11-15
NZ551153A (en) 2009-10-30
AU2004318214A1 (en) 2005-10-20
AU2004318214B2 (en) 2007-12-06
CA2562532C (en) 2010-02-16
CA2562532A1 (en) 2005-10-20
RU2328501C1 (ru) 2008-07-10
BRPI0418726A (pt) 2007-09-11
US20050228012A1 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
NO20065144L (no) Krystallinsk clopidogrelnaftalensulfonat eller hydrat derav, fremgangsmate for fremstilling derav, og farmasoytisk preparat inneholdende dette
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
DK1695965T3 (da) Krystallinsk betaform af ivabradin-hydrochlorid, fremgangsmåde til fremstilling heraf og famceutiske sammensætninger indeholdende denne
UY29479A1 (es) Inhibidores de adn-pk
DK1598333T3 (da) Fremgangsmåde til fremstilling af (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutan og syreadditionssalte heraf samt anvendelse til syntese af ivabradin og syreadditionssalte heraf med farmaceutisk acceptable syrer
NO20080784L (no) Histondeacetylaseinhibitorer
NO20091424L (no) Substituerte amider, fremgangsmåte for fremstilling derav og anvendelse derav
FI20055416A0 (fi) Bioabsorvoituva nauhajärjestelmä, bioabsorboituva nauha, menetelmä bioabsorboituvan nauhan valmistamiseksi, bioabsorboituvan nauhan neulajärjestelmä sekä lukitusmekanismi
DK1707562T3 (da) Krystallinsk v-form af ivabradin-hydrochlorid, fremgangsmåde til fremstilling heraf og famaceutiske sammensætninger, som indeholder denne
DK3219328T3 (da) Humane anti-il-23-antistoffer, sammensætninger, fremgangsmåder og anvendelser
DK1711494T3 (da) Arylsubstituerede heterocykler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20064454L (no) Matstang og fremgangsmåte for fremstilling derav.
NO2013008I1 (no) Krizotinib eller et farmasøytisk akseptabelt salt,hydrat eller solvat derav
IL186523A0 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
NO20082395L (no) Krystallinske former av 1'-(1-metyl)-4'-[(2-fluor-4-metoksyfenyl)metyl]-5'-metyl-1H-pyrazol-3'-O-beta-D-glucopyranosid, en fremstillingsmetode og anvendelse av denne for fremstilling av medikamenter
DK1695710T3 (da) Krystallinsk betad-form af ivabradinhydrochlorid, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende denne
IL179424A0 (en) Substituted oxazole -benzoisothiazole dioxide derivatives, process for their preparation and their use
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
NO20082256L (no) Pyrazolderivater, preparater som inneholder slike forbindelser, og fremgangsmåter for anvendelse
EP1797967A4 (en) ORGANIC THIN FILM PROCESSING, ORGANIC THIN FILM TRAINING AND SOLUTION FOR ORGANIC THIN FILM EDUCATION
DE602004013405D1 (de) Polymorphe formen von valsartan
NO20053809D0 (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
DE602005015459D1 (de) Folienherstellungsverfahren
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten
DK1994005T3 (da) Tetrahydronaphthalinderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelseshæmmere

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application